5
Clinical Trials associated with SJP-0132A Randomized, Double-masked, Parallel, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of SJP-0132 Eye Drops Compared With Placebo in Chinese Patients With Dry Eye Disease
This study will evaluate the safety and efficacy of SJP-0132 in Chinese Patients with Dry Eye.
Patients will be randomly assigned to receive either SJP-0132 or placebo.
SJP-0132 Phase 3 -Multicenter, Open-label, Long-term Study in Patients with Dry Eye Disease-
Start Date25 Jan 2023 |
Sponsor / Collaborator- |
SJP-0132 Phase 3 - Multicenter, Randomized, Double-Masked, Placebo Controlled, Parallel-Group Study in Patients with Dry Eye Disease -
Start Date19 Jan 2023 |
Sponsor / Collaborator- |
100 Clinical Results associated with SJP-0132
100 Translational Medicine associated with SJP-0132
100 Patents (Medical) associated with SJP-0132
100 Deals associated with SJP-0132